19 reports of this reaction
1.8% of all SILVER NITRATE reports
#7 most reported adverse reaction
STOMA SITE ERYTHEMA is the #7 most commonly reported adverse reaction for SILVER NITRATE, manufactured by Boiron. There are 19 FDA adverse event reports linking SILVER NITRATE to STOMA SITE ERYTHEMA. This represents approximately 1.8% of all 1,031 adverse event reports for this drug.
Patients taking SILVER NITRATE who experience stoma site erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
STOMA SITE ERYTHEMA is a less commonly reported adverse event for SILVER NITRATE, but still significant enough to appear in the safety profile.
In addition to stoma site erythema, the following adverse reactions have been reported for SILVER NITRATE:
STOMA SITE ERYTHEMA has been reported as an adverse event in 19 FDA reports for SILVER NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
STOMA SITE ERYTHEMA accounts for approximately 1.8% of all adverse event reports for SILVER NITRATE, making it a notable side effect.
If you experience stoma site erythema while taking SILVER NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.